About Collabrix
Collabrix is a Healthcare company based in Houston (United States) founded in 2018. It provides digital platform for life sciences collaboration with partners using blockchain. It operates on a B2B and SaaS model. Collabrix offers products and services including Alpatia and Mosymphony. Its focus areas include Life Sciences, Therapy Management, Cell and Gene and Life Sciences Tech. Its competitors include Innovative Technology Partners, The Contract Network, XO Life, Molecule and NotedSource and 3 more; 6 of its 8 listed competitors have raised funding.
Company details
Collabrix is a digital platform that facilitates collaboration among life sciences firms, CDMOs, hospitals, and logistics partners using blockchain technology. It enables transparent transactions, streamlined workflows, and integrations with systems like MES and QMS. Based in Houston, TX, it serves clients in cell and gene therapy, pharmaceutical manufacturing, and external testing labs, enhancing efficiency and trust in healthcare operations.
- Headquarters Houston, United States
- SectorsHealthcare
- Email••••••••
- Website collabrix.co
- InvestorsQuentelle
& 1 more
Products & Services of Collabrix
Collabrix offers a comprehensive portfolio of products and services, including Alpatia and Mosymphony.
Platform for collaborating on cell and gene therapy operations.
Tool for managing external manufacturing transactions between sponsors and CDMOs.
Funding Insights of Collabrix
- Total Rounds 1
- Investors Count 2
All 1 funding rounds of Collabrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2022 | – | Series A | – | Quentelle, ThinKuvate | – |
2 investors in total: 2 institutional.
Investors in Collabrix
Collabrix has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Quentelle and ThinKuvate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | thinkuvate.com | - | |
- | – | quentelle.com | - |
Investor details for Collabrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Collabrix
2 dated milestones of Collabrix across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Collabrix is founded.
- Funding First funding round.
Competitors of Collabrix
Collabrix has 8 listed competitors in our database, 6 of them funded. They include Innovative Technology Partners, The Contract Network, XO Life, Molecule and NotedSource, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| techspert.com | 2000 | Minneapolis, United States | $18.75M | 53 | Leading expert network for healthcare and life sciences | |
| thecontractnetwork.com | 2021 | Atlanta, United States | $6.87M | – | A digital platform is used for clinical trial contract collaboration. | |
| xo-life.com | 2016 | Munich, Germany | $10.06M | – | Pharmacovigilance and patient engagement platform is provided for pharmacies. | |
| molecule.ca | 2018 | Kingston, Canada | $2.18M | 13 | Cannabis-infused beverages are developed and marketed by Molecule. | |
| notedsource.io | 2021 | New York, United States | $2M | – | AI-powered platform for research collaboration and expertise matching is provided. | |
| bioneex.com | 2018 | Berlin, Germany | $500,000 | – | SaaS platform for biopharma drug licensing and partnerships is provided. | |
| scitok.com | 2018 | San Francisco, United States | – | – | Video platform for research sharing and scientist collaboration is provided. | |
| rndcircle.io | 2023 | Seoul, South Korea | – | – | AI-based platform is provided for R&D partner matching. |
Detailed competitors of Collabrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cell Therapy
10 companies that operate in the same segment as Collabrix (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 253 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Collabrix
Collabrix was founded in 2018 and raised its 1st funding round 4 years after it was founded.
Collabrix is headquartered in Houston, United States. It is registered at Houston, Texas, United States.
Collabrix is a digital platform that facilitates collaboration among life sciences firms, CDMOs, hospitals, and logistics partners using blockchain technology. It enables transparent transactions, streamlined workflows, and integrations with systems like MES and QMS. Based in Houston, TX, it serves clients in cell and gene therapy, pharmaceutical manufacturing, and external testing labs, enhancing efficiency and trust in healthcare operations.
Collabrix's top competitors include Innovative Technology Partners, XO Life and The Contract Network.
Collabrix offers Alpatia and Mosymphony.
Collabrix has 2 investors. Key investors include Quentelle, and ThinKuvate.